Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,446,612
+$2,074,736 QoQ
Shares Held
4,541
+23.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#1,650
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mission Creek Capital Partners, Inc. holds $22,770,041 across 9 Drug Manufacturers - General names. LLY ranks #2 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,974 | $9,644,256 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
4,541 | $5,446,612 | |
| 3 | AMGN |
Amgen Inc
|
14,051 | $5,088,148 | |
| 4 | ABBV |
AbbVie Inc.
|
17,933 | $887,331 | |
| 5 | PFE |
Pfizer Inc
|
22,248 | $535,731 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,080 | $395,780 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,542 | $321,156 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,250 | $244,885 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,446,612 | 4,541 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,371,876 | 3,666 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,406,735 | 3,170 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,187,521 | 2,867 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $958,821 | 1,230 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,043,950 | 1,264 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $961,140 | 1,245 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,542,647 | 2,870 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,508,807 | 2,771 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $981,007 | 1,261 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||